Study suggests COVID-19 could be a potential trigger for ME/CFS.
Low-dose Naltrexone may reduce Myalgic Encephalomyelitis/Chronic Fatigue Syndrome symptoms study finds.
In a world first, Gold Coast researchers have made an important breakthrough in understanding the cause of Chronic Fatigue Syndrome.
Griffith University has developed the first needle-free vaccine for Strep A with the potential to help millions from suffering, uncovered the history of Aboriginal Australians in a world first genomic study and celebrated a scientist being named 2017 Queensland Australian of the Year – all in one short year.
A diagnostic test for Chronic Fatigue Syndrome could be available within five years following the awarding of $4 million in funding to one of Australia’s foremost authorities on the condition.
Chronic Fatigue Syndrome researchers have discovered a cell receptor which could be a key contributing factor to CFS, providing a much clearer picture of how to tackle the debilitating illness.
New findings regarding the pathology of Chronic Fatigue Syndrome (CFS) are bringing Griffith University researchers closer to identifying the cause of this disabling illness.